Φορτώνει......
Can individualized sunitinib dose and schedule changes optimize outcomes for kidney cancer patients?
The recommended starting dose and schedule for sunitinib is 50 mg daily for 28 days, followed by a 14-day break with significant dose reductions to 37.5 mg (75% of starting dose), and then 25 mg (50% of starting dose) on the same schedule (four/two schedule). There are several reasons why these dose...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Can Urol Assoc J |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Canadian Medical Association
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215304/ https://ncbi.nlm.nih.gov/pubmed/28096939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.4293 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|